optimi health

Psychedelic Business Spotlight – June 10

June 10, 2022June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon; Numinus completed the acquisition of Novamind, MindMed’s stock is removed from an index; and more!

Psychedelic Business Spotlight – May 20

May 20, 2022June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: Another psychedelic merger; an Optimi Health acquisition; and good news for alcohol abuse treatment.

Psychedelic Business Spotlight – April 29

April 29, 2022June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: Field Trip Health splits in two, Tryp Therapeutics commences study, and Optimi Health celebrates new facility.

Psychedelic Business Spotlight – March 18

March 18, 2022June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: A psychedelics company folds; Ketamine Wellness Centers expand; Nova Mentis funds psilocybin studies.

Psychedelic Business Spotlight – March 4

March 4, 2022June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: Field Trip partners with Cerebral; Benzinga forms Psychedelic Advisory Council; Incannex pursues virtual reality psychedelic therapy.

Psychedelic Business Spotlight – January 21

January 21, 2022June 2, 2024 Business, Learn, Stock Reports

Catch up on some of the biggest psychedelic business developments that unfolded in the last week.

Psychedelic Business Spotlight: October 8, 2021

October 8, 2021June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: Enveric Biosciences uses AI to identify viable psychedelic drug candidates; Novamind launches end-of-life palliative care program; and PharmaTher tests ketamine to treat Parkinson’s Disease.

End of content